Dogwood Equity logo

Dogwood Equity

North America, North Carolina, United States, Raleigh

Description

Dogwood Equity provides equity investments in control buyouts and in closely-held companies located in the Southeastern United States.

Investor Profile

Dogwood Equity has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series D (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dogwood Equity frequently co-invest with?

Mitsui & Co
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Franklin Street Partners
North America, North Carolina, United States, Chapel Hill
Co-Investments: 1
Tall Oaks Capital Partners
North America, Virginia, United States, Charlottesville
Co-Investments: 1
Dow
North America, Michigan, United States, Midland
Co-Investments: 2
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
KH
North America, North Carolina, United States, Charlotte
Co-Investments: 1
AC
North America, North Carolina, United States, Durham
Co-Investments: 1
Quaker BioVentures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
TT
North America, North Carolina, United States, Cary
Co-Investments: 1

What are some of recent deals done by Dogwood Equity?

Biolex Therapeutics

Pittsboro, North Carolina, United States

Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.

BiotechnologyHealth CareMedical
Series DOct 6, 2008
Amount Raised: $60,000,000
Biolex Therapeutics

Pittsboro, North Carolina, United States

Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.

BiotechnologyHealth CareMedical
Series UnknownAug 21, 2003
Amount Raised: $24,400,000